Analysis of advanced glycation end products in the DHS Mind Study

Jeremy N. Adams, Susan E. Martelle, Laura M. Raffield, Barry I. Freedman, Carl D. Langefeld, Fang Chi Hsu, Joseph A Maldjian, Jeff D. Williamson, Christina E. Hugenschmidt, J. Jeffery Carr, Amanda J. Cox, Donald W. Bowden

Research output: Contribution to journalArticle

2 Scopus citations

Abstract

Aims Human studies of links between advanced glycation end-products (AGEs) and disease phenotypes are less common than studies of animal and cell models. Here, we examined the association of total AGEs with diabetes risk factors in a predominately type 2 diabetes (T2D) affected cohort. Methods AGEs were measured using an enzyme linked immunosorbant assay in 816 individuals from the DHS Mind Study (n = 709 T2D affected), and association analyses were completed. Results Total AGEs were associated with estimated glomerular filtration rate (p = 0.0054; β = - 0.1291) and coronary artery calcification (p = 0.0352; β = 1.1489) in the entire cohort. No significant associations were observed when individuals with T2D were analyzed separately. In individuals without T2D, increased circulating AGEs were associated with increased BMI (p = 0.02, β = 0.138), low density lipoproteins (p = 0.046, β = 17.07) and triglycerides (p = 0.0004, β = 0.125), and decreased carotid artery calcification (p = 0.0004, β = - 1.2632) and estimated glomerular filtration rate (p = 0.0018, β = - 0.1405). Strong trends were also observed for an association between AGEs and poorer cognitive performance on the digit symbol substitution test (p = 0.046, β = - 6.64) and decreased grey matter volume (p = 0.037, β = - 14.87). Conclusions AGEs may play an important role in a number of phenotypes and diseases, although not necessarily in interindividual variation in people with T2D. Further evaluation of specific AGE molecules may shed more light on these relationships.

Original languageEnglish (US)
Pages (from-to)262-268
Number of pages7
JournalJournal of Diabetes and Its Complications
Volume30
Issue number2
DOIs
StatePublished - Mar 1 2016

Keywords

  • Advanced glycation end products
  • Cardiovascular disease
  • Cognition
  • Grey matter volume
  • Neuroimaging
  • Type 2 diabetes

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Fingerprint Dive into the research topics of 'Analysis of advanced glycation end products in the DHS Mind Study'. Together they form a unique fingerprint.

  • Cite this

    Adams, J. N., Martelle, S. E., Raffield, L. M., Freedman, B. I., Langefeld, C. D., Hsu, F. C., Maldjian, J. A., Williamson, J. D., Hugenschmidt, C. E., Carr, J. J., Cox, A. J., & Bowden, D. W. (2016). Analysis of advanced glycation end products in the DHS Mind Study. Journal of Diabetes and Its Complications, 30(2), 262-268. https://doi.org/10.1016/j.jdiacomp.2015.11.025